The Community Guide

- gsearch

Search Results

Narrow Results:

2018 1

Journal Article 1

1 Results

Refine Results

Refine Results:

Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy

CITE Title : Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy Personal Author(s) : Haaland, Richard E.;Otieno, Kephas;Martin, Amy;Katana, Abraham;Dinh, Chuong;Slutsker, Laurence;Menendez, Clara;Gonzalez, Raquel;Williamson, John;Heneine, Walid;Desai, Meghna; Published Date : Oct 17 2018 Source : AIDS Res Hum Retroviruses. 2018; 34(11):912-915. URL : https://stacks.cdc.gov/view/cdc/60780 Haaland, Richard E. et al. (2018). Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy. 34(11). Haaland, Richard E. et al. "Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy" 34, no. 11 (2018) Haaland, Richard E. et al. "Short Communication: Reduced Nevirapine Concentrations Among HIV-Positive Women Receiving Mefloquine for Intermittent Preventive Treatment for Malaria Control During Pregnancy" vol. 34, no. 11, 2018 Export RIS Citation Information.

:

Haaland, Richard E. ;

Otieno, Kephas

Oct 17 2018 | AIDS Res Hum Retroviruses. 2018; 34(11):912-915.

:

Clinical trials demonstrated intermittent preventive treatment in pregnancy with mefloquine (MQ) reduced malaria rates among pregnant women, yet an un...

To see more results, try removing search filters or changing the search terms